What Researchers Did
Researchers investigated the concurrent use of hyperbaric oxygen therapy (HBOT) and intratympanic steroid application (ITS) as a salvage therapy for severe sudden sensorineural hearing loss (SSNHL).
What They Found
They found that concurrent hyperbaric oxygen therapy (HBOT) and intratympanic steroid application (ITS) were beneficial as a salvage therapy for therapy-refractory sudden sensorineural hearing loss (SSNHL). These findings encourage further investigation into this combined treatment for noise-induced and idiopathic SSNHL, including long-term or therapy-refractory cases.
What This Means for Canadian Patients
Canadian patients experiencing severe sudden sensorineural hearing loss that has not responded to initial treatments might benefit from this combined therapy. This approach could offer a new option for those with long-term or difficult-to-treat hearing loss, potentially improving their hearing outcomes.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
A key limitation is that the abstract does not provide details on study design or sample size, which are crucial for assessing the generalizability of the findings.